Cognoptix is a pioneering company in the healthcare technology sector, specializing in non-invasive diagnostics for Alzheimer’s Disease. Their innovative beta amyloid eye scanning test offers a simple and efficient method for evaluating adult patients, enhancing early detection and improving patient outcomes in Alzheimer’s diagnostics.
Specialties
Non-Invasive Alzheimer’s Diagnostics
Beta Amyloid Eye Scanning Test
Early Detection of Alzheimer's
Healthcare Technology Innovation
Patient-Centric Diagnostic Solutions
Products & Services
Beta Amyloid Eye Scanning Test
Alzheimer's Disease Diagnostics
Non-Invasive Medical Devices
Healthcare Technology Solutions
Patient Evaluation Tools
Contact Information
No contact information available
Competitors & Similar Companies(5)
Neurotrack
Axovant Gene Therapies
Biogen
Eli Lilly and Company
Alzheon
News & Media
Search Terms:
cognoptix
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Cognoptix
Where is Cognoptix located?
The headquarter of Cognoptix is located in Acton, Massachusetts, United States
Competitors of Cognoptix are Neurotrack, Axovant Gene Therapies, Biogen, Eli Lilly and Company, Alzheon.
What does Cognoptix do?
Cognoptix is a pioneering company in the healthcare technology sector, specializing in non-invasive diagnostics for Alzheimer’s Disease. Their innovative beta amyloid eye scanning test offers a simple and efficient method for evaluating adult patients, enhancing early detection and improving patient outcomes in Alzheimer’s diagnostics.